
Volume: | 54,554 |
Day Range: | 4.41 - 4.58 |
Bid: | 4.10 |
Ask: | 4.64 |
Last Trade Time: | 5:31:35 PM EDT |
Total Trades: | 483 |
Recent DTIL News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/04/2025 11:38:08 AM
- Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference • Business Wire • 04/01/2025 11:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/28/2025 11:02:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/28/2025 11:00:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2025 11:00:04 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/26/2025 10:09:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/26/2025 09:03:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2025 11:30:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2025 11:30:08 AM
- Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update • Business Wire • 03/26/2025 11:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2025 10:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/24/2025 07:13:05 PM
- Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025 • Business Wire • 03/21/2025 11:01:00 AM
- Precision BioSciences Presents Preclinical Safety and Efficacy Data Supporting Repeat Dosing of PBGENE-HBV With a Goal of Curing Chronic Hepatitis B at the Global Hepatitis Summit 2025 • Business Wire • 03/20/2025 11:01:00 AM
- Precision BioSciences Presents Preclinical Efficacy and Durability Data on PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy (DMD) at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference • Business Wire • 03/19/2025 11:01:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/18/2025 09:13:30 PM
- Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B • Business Wire • 03/17/2025 11:01:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2025 09:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:00:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:00:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 12:00:10 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2025 08:17:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2025 09:13:50 PM
- Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference • Business Wire • 02/24/2025 12:01:00 PM
- Precision BioSciences Announces Initial Safety and Antiviral Activity of PBGENE-HBV in the ELIMINATE-B Clinical Trial • Business Wire • 02/19/2025 12:01:00 PM
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers • HLYK • Apr 14, 2025 8:00 AM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM
Opus Holdings, Inc. (OTC: CATV) Reports Nearly $500K in Q4 Revenue, eliminates $830K in Debt, and Appoints Visionary CEO to Lead Bold Transformation • CATV • Apr 10, 2025 9:34 AM
AI-Powered Service Robots Redefine Hospitality as Industry Innovators Lead the Charge • NGTF • Apr 10, 2025 9:00 AM
UAV Corp Powers Forward: T-Wing Nears Completion, Global Momentum Accelerates with Saudi Arabia in Sight • UMAV • Apr 10, 2025 8:30 AM
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV • FITY • Apr 9, 2025 9:00 AM